Worth Venture Partners, LLC Neu Base Therapeutics, Inc. Transaction History

Worth Venture Partners, LLC

  • $12 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$0.41 - $1.3 $18,252 - $57,873
-44,518 Reduced 17.35%
212,035 $84,000
Q1 2022

May 16, 2022
BUY
$1.26 - $2.95 $34,398 - $80,535
27,300 Added 11.91%
256,553 $482,000
Q4 2021

Feb 14, 2022
BUY
$2.6 - $4.18 $596,057 - $958,277
229,253 New
229,253 $644,000

About NeuBase Therapeutics, Inc.

NBSE Quotes by TradingView
  • Ticker NBSE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,258,700
  • Description
  • NeuBase Therapeutics, Inc., a pre-clinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as ...
More about NBSE
Track This Portfolio

Track Worth Venture Partners, LLC Portfolio

Follow Worth Venture Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Worth Venture Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Worth Venture Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email